The S&P 500 and Nasdaq eked out small gains on Wednesday to extend their recent winning streaks as investors weighed Federal Reserve officials' recent comments for signals on the path of interest rates and focused on the direction of Treasury yields.
US Treasury yields have retreated sharply since the benchmark 10-year Treasury note topped 5 percent in late October, as comments from Fed officials and softer labor data led to growing expectations the central bank had reached the end of its rate-hike cycle.
That drop has helped fuel a stock rally that has given the S&P 500 and the Nasdaq their longest streak of gains in two years through Wednesday's close at eight and nine sessions, respectively.
Markets are pricing in about a 50 percent chance of a rate cut of at least 25 basis points as soon as May, according to the CME Group's FedWatch Tool, up from about 41 percent a week earlier.
Still, comments from several central bank officials over the past few days left the door open for additional hikes, causing some uncertainty among investors.
"Everyone kind of knows we're either going to get one more hike or they're done and they're probably done," said Jason Ware, chief investment officer at Albion Financial Group.
"If we get a recession stocks have a different valuation, earnings look different. If we don't then we're probably in the context of a new early stage bull market here," he said.
"That's the question that investors are going to be asking themselves while watching yields - the information we get between now and the end of the year on yields and economic data as it relates to recession is going to drive the tape."
The Dow Jones Industrial Average fell 0.12 percent, to 34,112; the S&P 500 gained 0.10 percent, at 4,383; and the Nasdaq Composite added 0.08 percent, at 13,650. The Dow's decline snapped a seven-session winning streak.
Eli Lilly shares climbed 3.2 percent after the US Food and Drug Administration approved the drugmaker's weight loss treatment.
In earnings, Warner Bros Discovery plunged 19 percent after the media and entertainment conglomerate said Hollywood strikes and a weak advertising market could hurt 2024 earnings, weighing on peer Paramount Global. (Reuters)